CHAIR
:
SPEAKER
(S):
Eliezer Katz,
DrMed,MD (SPKNON), Senior Director, Transplantation, Medicines Development Group,
Pfizer Specialty Care, United States
Dr. Katz joined is currently Senior Director at Pfizer SpecialtyCare Transplantation Medical Affairs. Prior to joining Pfizer Dr. Katz was the VP of Medical Affairs at CTI Clinical Trial and Consulting Services. Dr. Katz is a transplant surgeon and was the director of two transplant programs.
|
Dorry Segev, MD (SPKSUP), Associate Professor of Surgery, Div. of Transplantation, Dept of Surgery, Johns Hopkins University School of Medicine, United States
William Irish, PhD,MSc (SPKNON), CTI Clinical Trial and Consulting Services, United States
Description
Clinical trials are considered the gold standard for determining the efficacy of a therapeutic but operate in an idealized patient setting, only measuring efficacy in restrictive populations. As such, they may not provide a true indication of effectiveness within a diversified target population. Data retrieved from electronic medical records (EMRs) allow for the examination of health care utilization patterns and associated outcomes in a real-world setting. This unique data collection approach will provide new insights on therapeutic treatment options used in practice for minimal cost, time and effort. This session will present real-world examples in solid organ transplantation to illustrate the challenges in utilizing site EMR systems.